Daniela L. Uliana

Bandeirantes Avenue 3900
Ribeirao Preto, SP 14049900, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Antipsychotic drug action, novel treatment targets, and the failure of current clinical trial designs in evaluating new target molecules.

Antipsychotic drug action, novel treatment targets, and the failure of current clinical trial designs in evaluating new target molecules.

Journal: Biological psychiatry

Published: April 10, 2026

Parvalbumin and anxiety across development in female offspring of the MAM neurodevelopmental model of schizophrenia.

Parvalbumin and anxiety across development in female offspring of the MAM neurodevelopmental model of schizophrenia.

Journal: Journal of psychiatric research

Published: February 19, 2026

Novel positive allosteric modulators of alpha 5 subunit-containing GABAA receptors (α5-GABAARs) reverse the hyperdopaminergic state in a neurodevelopmental model of schizophrenia.

Novel positive allosteric modulators of alpha 5 subunit-containing GABAA receptors (α5-GABAARs) reverse the hyperdopaminergic state in a neurodevelopmental model of schizophrenia.

Journal: Schizophrenia research

Published: November 03, 2025

Prefrontal Cortex Dysfunction as a Precipitating Factor for Schizophrenia and Depression.

Prefrontal Cortex Dysfunction as a Precipitating Factor for Schizophrenia and Depression.

Journal: Journal of neurochemistry

Published: October 31, 2025

Age- and sex-dependent effects of stressors on activity of the nucleus reuniens of the thalamus.

Age- and sex-dependent effects of stressors on activity of the nucleus reuniens of the thalamus.

Journal: Schizophrenia research

Published: June 18, 2025

The ventral/anterior hippocampus as a central hub for stress-related dopaminergic circuit dysfunction in psychiatric disorders.

The ventral/anterior hippocampus as a central hub for stress-related dopaminergic circuit dysfunction in psychiatric disorders.

Journal: Molecular psychiatry

Published: May 23, 2025

Evenamide reverses schizophrenia-related dysfunction in a neurodevelopmental animal model.

Evenamide reverses schizophrenia-related dysfunction in a neurodevelopmental animal model.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Published: May 09, 2025

THPP-1 PDE10A inhibitor reverses the cognitive deficits and hyperdopaminergic state in a neurodevelopment model of schizophrenia.

THPP-1 PDE10A inhibitor reverses the cognitive deficits and hyperdopaminergic state in a neurodevelopment model of schizophrenia.

Journal: Schizophrenia research

Published: March 22, 2024

Pioglitazone attenuates behavioral and electrophysiological dysfunctions induced by two-hit model of schizophrenia in adult rodent offspring.

Pioglitazone attenuates behavioral and electrophysiological dysfunctions induced by two-hit model of schizophrenia in adult rodent offspring.

Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

Published: February 23, 2024

The excitatory-inhibitory balance as a target for the development of novel drugs to treat schizophrenia.

The excitatory-inhibitory balance as a target for the development of novel drugs to treat schizophrenia.

Journal: Biochemical pharmacology

Published: February 01, 2024

Insights into the Mechanism of Action of Antipsychotic Drugs Derived from Animal Models: Standard of Care versus Novel Targets.

Insights into the Mechanism of Action of Antipsychotic Drugs Derived from Animal Models: Standard of Care versus Novel Targets.

Journal: International journal of molecular sciences

Published: June 28, 2023

Update on current animal models for schizophrenia: are they still useful?

Update on current animal models for schizophrenia: are they still useful?

Journal: Current opinion in psychiatry

Published: February 10, 2023

Showing 1-12 of 32

Last Updated: 09/26/2026